Koru Medical Systems Inc (KRMD)

$2.56

-0.04

(-1.54%)

Market is closed - opens 7 PM, 25 Jul 2024

Performance

  • $2.53
    $2.65
    $2.56
    downward going graph

    1.17%

    Downside

    Day's Volatility :4.35%

    Upside

    3.21%

    downward going graph
  • $1.98
    $3.12
    $2.56
    downward going graph

    22.66%

    Downside

    52 Weeks Volatility :36.54%

    Upside

    17.95%

    downward going graph

Returns

PeriodKoru Medical Systems IncIndex (Russel 2000)
3 Months
18.18%
0.0%
6 Months
23.22%
0.0%
1 Year
-8.45%
0.0%
3 Years
-25.07%
-19.9%

Highlights

Market Capitalization
120.4M
Book Value
$0.42
Earnings Per Share (EPS)
-0.29
Wall Street Target Price
3.5
Profit Margin
-45.24%
Operating Margin TTM
-23.93%
Return On Assets TTM
-17.44%
Return On Equity TTM
-54.24%
Revenue TTM
29.3M
Revenue Per Share TTM
0.64
Quarterly Revenue Growth YOY
10.9%
Gross Profit TTM
15.4M
EBITDA
-8.3M
Diluted Eps TTM
-0.29
Quarterly Earnings Growth YOY
-0.66
EPS Estimate Current Year
-0.16
EPS Estimate Next Year
-0.09
EPS Estimate Current Quarter
-0.04
EPS Estimate Next Quarter
-0.04

Analyst Recommendation

Buy
    90%Buy
    9%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for Koru Medical Systems Inc(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 36.72%

Current $2.56
Target $3.50

Company Financials

FY18Y/Y Change
Revenue
17.4M
↑ 12.37%
Net Income
910.6K
↑ 11.11%
Net Profit Margin
5.25%
↓ 0.06%
FY19Y/Y Change
Revenue
23.2M
↑ 33.47%
Net Income
564.3K
↓ 38.02%
Net Profit Margin
2.44%
↓ 2.81%
FY20Y/Y Change
Revenue
24.2M
↑ 4.38%
Net Income
-1.2M
↓ 314.77%
Net Profit Margin
-5.01%
↓ 7.45%
FY21Y/Y Change
Revenue
23.5M
↓ 2.84%
Net Income
-4.6M
↑ 276.45%
Net Profit Margin
-19.42%
↓ 14.41%
FY22Y/Y Change
Revenue
27.9M
↑ 18.76%
Net Income
-8.7M
↑ 89.82%
Net Profit Margin
-31.05%
↓ 11.63%
FY23Y/Y Change
Revenue
28.5M
↑ 2.23%
Net Income
-13.7M
↑ 58.65%
Net Profit Margin
-48.18%
↓ 17.13%
Q4 FY22Q/Q Change
Revenue
7.3M
↓ 5.36%
Net Income
-2.0M
↑ 61.29%
Net Profit Margin
-26.91%
↓ 11.12%
Q1 FY23Q/Q Change
Revenue
7.4M
↑ 0.65%
Net Income
-2.4M
↑ 21.96%
Net Profit Margin
-32.61%
↓ 5.7%
Q2 FY23Q/Q Change
Revenue
6.9M
↓ 6.18%
Net Income
-2.5M
↑ 3.53%
Net Profit Margin
-35.98%
↓ 3.37%
Q3 FY23Q/Q Change
Revenue
7.0M
↑ 0.97%
Net Income
-1.4M
↓ 45.18%
Net Profit Margin
-19.54%
↑ 16.44%
Q4 FY23Q/Q Change
Revenue
7.2M
↑ 2.61%
Net Income
-7.5M
↑ 445.66%
Net Profit Margin
-103.9%
↓ 84.36%
Q1 FY24Q/Q Change
Revenue
8.2M
↑ 14.08%
Net Income
-1.9M
↓ 74.07%
Net Profit Margin
-23.62%
↑ 80.28%
FY18Y/Y Change
Total Assets
10.5M
↑ 13.62%
Total Liabilities
1.6M
↓ 1.67%
FY19Y/Y Change
Total Assets
13.9M
↑ 31.64%
Total Liabilities
2.6M
↑ 67.01%
FY20Y/Y Change
Total Assets
39.9M
↑ 187.56%
Total Liabilities
3.8M
↑ 42.19%
FY21Y/Y Change
Total Assets
41.3M
↑ 3.44%
Total Liabilities
4.8M
↑ 27.38%
FY22Y/Y Change
Total Assets
42.3M
↑ 2.52%
Total Liabilities
11.0M
↑ 129.69%
FY23Y/Y Change
Total Assets
28.5M
↓ 32.77%
Total Liabilities
8.1M
↓ 26.34%
Q4 FY22Q/Q Change
Total Assets
42.3M
↓ 0.78%
Total Liabilities
11.0M
↑ 8.18%
Q1 FY23Q/Q Change
Total Assets
38.3M
↓ 9.63%
Total Liabilities
8.5M
↓ 23.16%
Q2 FY23Q/Q Change
Total Assets
36.0M
↓ 5.9%
Total Liabilities
7.9M
↓ 6.65%
Q3 FY23Q/Q Change
Total Assets
35.4M
↓ 1.78%
Total Liabilities
7.9M
↑ 0.37%
Q4 FY23Q/Q Change
Total Assets
28.5M
↓ 19.5%
Total Liabilities
8.1M
↑ 2.32%
Q1 FY24Q/Q Change
Total Assets
27.5M
↓ 3.37%
Total Liabilities
8.4M
↑ 3.4%
FY18Y/Y Change
Operating Cash Flow
1.5M
↑ 64.42%
Investing Cash Flow
-1.7M
↑ 557.39%
Financing Cash Flow
14.4K
↓ 174.53%
FY19Y/Y Change
Operating Cash Flow
320.6K
↓ 78.33%
Investing Cash Flow
1.3M
↓ 175.74%
Financing Cash Flow
501.3K
↑ 3374.23%
FY20Y/Y Change
Operating Cash Flow
-743.3K
↓ 331.84%
Investing Cash Flow
-1.0M
↓ 179.08%
Financing Cash Flow
23.2M
↑ 4532.75%
FY21Y/Y Change
Operating Cash Flow
-4.3M
↑ 481.11%
Investing Cash Flow
-366.2K
↓ 64.66%
Financing Cash Flow
2.7M
↓ 88.35%
FY22Y/Y Change
Operating Cash Flow
-5.4M
↑ 25.12%
Investing Cash Flow
-2.8M
↑ 665.1%
Financing Cash Flow
279.5K
↓ 89.67%
Q4 FY22Q/Q Change
Operating Cash Flow
1.3M
↓ 163.17%
Investing Cash Flow
-223.9K
↓ 65.5%
Financing Cash Flow
-145.6K
↓ 115.49%
Q1 FY23Q/Q Change
Operating Cash Flow
-4.7M
↓ 448.72%
Investing Cash Flow
-283.8K
↑ 26.79%
Financing Cash Flow
-239.0K
↑ 64.13%
Q2 FY23Q/Q Change
Operating Cash Flow
-153.9K
↓ 96.7%
Investing Cash Flow
-108.7K
↓ 61.7%
Financing Cash Flow
-242.8K
↑ 1.61%

Technicals Summary

Sell

Neutral

Buy

Koru Medical Systems Inc is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Koru Medical Systems Inc
Koru Medical Systems Inc
-8.13%
23.22%
-8.45%
-25.07%
-34.18%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
6.06%
22.97%
40.64%
41.31%
151.4%
Resmed Inc.
Resmed Inc.
15.0%
21.98%
-3.96%
-19.33%
67.01%
Becton, Dickinson And Company
Becton, Dickinson And Company
-0.67%
-0.1%
-16.3%
-6.05%
-8.55%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-4.48%
-9.33%
-15.92%
-16.25%
158.59%
Alcon Ag
Alcon Ag
1.12%
18.8%
8.85%
29.4%
54.04%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Koru Medical Systems Inc
Koru Medical Systems Inc
NA
NA
NA
-0.16
-0.54
-0.17
NA
0.42
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
79.37
79.37
7.13
6.56
0.16
0.08
NA
41.4
Resmed Inc.
Resmed Inc.
31.84
31.84
1.75
7.73
0.22
0.12
0.01
31.52
Becton, Dickinson And Company
Becton, Dickinson And Company
49.48
49.48
1.34
13.04
0.05
0.03
0.02
88.74
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
42.01
42.01
6.72
7.74
0.21
0.11
0.0
36.72
Alcon Ag
Alcon Ag
42.94
42.94
4.59
3.07
0.05
0.02
0.0
42.13
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Koru Medical Systems Inc
Koru Medical Systems Inc
Buy
$120.4M
-34.18%
NA
-45.24%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$163.9B
151.4%
79.37
27.65%
Resmed Inc.
Resmed Inc.
Buy
$30.5B
67.01%
31.84
20.91%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$66.8B
-8.55%
49.48
6.76%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$23.3B
158.59%
42.01
19.42%
Alcon Ag
Alcon Ag
Buy
$44.7B
54.04%
42.94
10.96%

Insights on Koru Medical Systems Inc

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 6.93M → 8.19M (in $), with an average increase of 5.3% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -7.46M → -1.93M (in $), with an average increase of 285.7% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 40.6% return, outperforming this stock by 49.1%

  • Vs ISRG

    In the last 3 years, Intuitive Surgical, Inc. has given 39.8% return, outperforming this stock by 65.9%

Institutional Holdings

  • First Light Asset Management, LLC

    11.41%
  • Archon Capital Management LLC

    8.63%
  • Vanguard Group Inc

    4.29%
  • BlackRock Inc

    3.54%
  • Geode Capital Management, LLC

    1.67%
  • B. Riley Asset Management, LLC

    1.62%

Company Information

repro medsystems inc is a company based out of 24 carpenter road, chester, new york, united states.

Organization
Koru Medical Systems Inc
Employees
82
CEO
Ms. Linda M. Tharby
Industry
Health Technology

FAQs